IASO Bio Celebrates Grand Opening of Shanghai Waigaoqiao Global R&D Center and Successfully Hosts Forum on China’s Cell Therapy Globalization

SHANGHAI, NANJING, and SAN FRANCISCO, May 20, 2025 /PRNewswire/ — IASO Biotherapeutics (“IASO Bio”), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies and antibody biologics, today marked two significant…